Omega 3 PUFA Market Size by Type, Source, Application, Region, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2034
Overview
The Omega 3 PUFA Market size was valued at USD 1.67 Billion in 2025 and the total Omega 3 PUFA revenue is expected to grow at a CAGR of 3.89% from 2026 to 2034, reaching nearly USD 2.35 Billion.
Omega-3 Polyunsaturated Fatty Acids are a kind of polyunsaturated fatty acid that is utilized to strengthen the cardiovascular system. These chemicals can be found in both marine and botanical sources. Omega 3 PUFA is essential for anti-inflammatory activities in the cell membrane, which improves immunity in the face of any illness to the human body. With a 46.3 percent market share, North America led the way, followed by the APAC region. EPA has been the most important constituent type in Omega-3 polyunsaturated fatty acids, accounting for 64.7 percent of the total.
Omega 3 PUFA Market Analysis from 2025 to 2034
To know about the Research Methodology:- Request Free Sample Report
Omega 3 PUFA Market Dynamics:
The market for Omega-3 PUFAs is growing as the frequency of cardiovascular illnesses rises. Unhealthy diets, cigarette use, and physical inactivity are only a few of the key causes of cardiovascular disease, which elevate blood pressure & blood glucose levels, resulting in overweight and obesity. According to the World Health Organization, the number of people dying from heart attacks and strokes is on the rise. As a result, the Omega-3 PUFA Market is expected to grow between 2026 and 2034.
The market for Disposable Negative Pressure Wound Therapy Devices is growing due to the rising prevalence of chronic illnesses. Chronic illnesses are the major cause of death all over the world. Chronic illnesses are thought to be responsible for roughly 29% of all fatalities in the United States, with chronic diseases afflicting 40.5 percent of the population. As a result, the Disposable Negative Pressure Wound Therapy Devices Market is expected to grow between 2026 and 2034.
Higher omega-3 PUFA prices and more competition are some of the factors that are expected to stymie the market's growth. During the forecast period 2026-2034, the market is expected to be hampered by stringent government restrictions and a lack of everyday use of nutritious items.
Omega 3 PUFA Market Segmentation Analysis:
By Type, The significant breakthroughs, such as emulsion and technologies like microencapsulation and stabilization, helped to overcome the problem of oxidation susceptibility, allowing EPA/DHA to be used in more food and beverage applications, particularly clear drinks. In fish oil formulations, the EPA is combined with DHA to treat a range of illnesses, including asthma, cancer, menstruation issues, hot flashes, hay fever, lung disorders, lupus erythematosus, and renal disease. The demand for EPA from infant formula, nutritional supplements, foods and drinks, and pharmaceutical sectors is increasing as a result of these health advantages, propelling the worldwide EPA/DHA market forward. ALA, on the other hand, is expected to expand at a faster rate than EPA/DHA throughout the forecast period, owing to rising demand for plant-based omega-3 PUFA from vegetarian and vegan customers throughout the world.
Plant-derived omega-3 PUFA is expected to grow at the quickest rate in the market over the forecast period. The rising propensity of the vegetarian population to eat goods containing ingredients or components derived from plant sources is attributable to the rapid growth of this market. However, marine-sourced omega-3 PUFA held the largest share of the global omega-3 PUFA market in 2017, owing to factors such as its wide range of applications in dietary supplements and infant formula, approval from leading organizations for its use in various products, and its widespread availability and production.
By Application, The gloabl Infant formula market is growing due to rising birth rates and parental buying power throughout the world. Infant formula is generally made from skimmed, processed cow's milk. The European Food Safety Authority (EFSA) has established that omega-3 fats, such as DHA and ALA, can help newborns' vision and cognition. In 2001, the US Food and Drug Administration allowed the use of DHA in baby formula, and now, the most popular formulas are DHA-fortified. Premature newborns and early infants can benefit from DHA-fortified formula.
Omega 3 PUFA Market Regional Insight:
In 2025, North America dominated the market, with a 35.3 percent share. This can be attributable to increased research and development as well as enhanced medicine penetration. The market in this area is growing due to rising dietary supplement usage, increased health advantages of omega-3 PUFA, rising healthcare spending, and improved healthcare infrastructure.
In the Global Omega 3 PUFA Market, Asia Pacific is expected to grow at a high rate. The growing demand from consumers for foods with high fiber content is responsible for the market's size. Large expanses of farmland and production of high-fiber content plants and oilseeds, which are the key raw materials for fiber and specialty carbohydrate components, are found in emerging nations in this region, such as India and China. Due to changing client lives, the food business in the Asia-Pacific region is experiencing slow growth. The Asia-Pacific food and beverage market is now undergoing a dramatic shift as a result of growing urbanization, diet diversity, and increased foreign direct investment in the food sector. These are the factors that are likely to boost product sales.
Report Objectives:
Landscape analysis of the Omega 3 PUFA Market
competitive benchmarking
Past and current status of the industry with the forecasted market size and trends
Evaluation of potential key players that include market leaders, followers, and new entrants
Technology trends
Potential impact of micro-economic factors of the market
External and Internal factors affecting market have been analysed
The report also helps in understanding the Omega 3 PUFA Market dynamics, structure by analysing the market segments and project the market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the market make the report investor’s guide.
Omega 3 PUFA Market Recent Development:
| Date | Company | Development | Impact |
|---|---|---|---|
| 28 January 2025 | Epax Norway AS | Epax announced a USD 10 million facility investment to construct a new synthesis plant at its primary facility in Ålesund, Norway. | The expansion enhances technical capabilities for modifying marine oil fractions and meeting ultra-tight contaminant specifications for high-purity concentrates. |
| 06 May 2025 | TopGum Industries | TopGum officially launched OMG3!, a novel microencapsulated gummy line featuring algae-sourced DHA tailored for maternal and pediatric dietary health. | The innovation enables higher thermal stability and taste masking, accelerating the adoption of plant-based omega-3 delivery formats in functional foods. |
| 01 October 2025 | Louis Dreyfus Company | Louis Dreyfus Company completed the strategic acquisition of BASF's Food and Health Performance Ingredients business, including its specialized omega-3 oil portfolio. | The transaction expands LDC's global presence in the human nutrition and refined lipid ingredients market through specialized production infrastructure in Europe. |
| 31 December 2025 | KD Pharma Group | KD Pharma Group completed the acquisition of dsm-firmenich’s marine lipids business, acquiring key fish oil concentrate assets and the MEG-3 brand platform. | The consolidation creates a dominant supply chain lead in pharmaceutical-grade EPA and DHA ingredients and high-potency nutritional supplements globally. |
| 14 April 2026 | Fermentalg | Fermentalg launched OMEGA ΩRIGINS™, a breakthrough microalgae-derived ingredient line containing balanced concentrations of natural EPA and DHA. | The commercial rollout offers supplement manufacturers a sustainable and non-marine alternative that supports cardiovascular, cognitive, and visual health claims. |
Omega 3 PUFA Market Scope: Inquire before buying
| Omega 3 PUFA Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | USD 1.67 Bn |
| Forecast Period 2026 to 2034 CAGR: | 3.89% | Market Size in 2034: | USD 2.35 Bn |
| Segments Covered: | by Type | Docosahexaenoic acid (DHA) Eicosapentaenoic acid (EPA) Alpha linoleic acid (ALA) |
|
| by Source | Marine Sources Fish oils Algal oils Krill oils Other Plant Source Flaxseed oil Chia Seed oil Other |
||
| by Application | Dietary supplements Functional foods & beverages Pharmaceuticals Infant formula Others |
||
Omega 3 PUFA Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Omega 3 PUFA Market, Key Players
1.Cargill Incorporated
2.FMC Corporation
3.Croda International PLC
4.Royal DSM
5.Omega Protein Corporation
6.Arista Industries Inc.
7.Denemoga
8.Polaris
9.Pharma Marine LLC.
10.GOED Omega 3
11.Croda International PLC
12.GC Rieber Oils
13.BASF SE
14.Pelagia AS
15.Koninklijke DSM NV
16.Arjuna Natural
17.Corbion NV
18.Archer Daniels Midland Company
Frequently Asked Questions
1. What is the projected market size & growth rate of Omega 3 PUFA Market?
Ans- The Omega 3 PUFA Market size was valued at USD 1.67 Billion in 2025 and the total Omega 3 PUFA revenue is expected to grow at a CAGR of 3.89% from 2026 to 2034, reaching nearly USD 2.35 Billion.
2. What is the key driving factor for the growth of Omega 3 PUFA Market?
Ans- The market for Omega-3 PUFAs is growing as the frequency of cardiovascular illnesses rises.
3. Which Region accounted for the largest market share?
Ans- In 2025, North America dominated the market, with a 35.3 percent share.
4. What makes North America a Lucrative Market for Omega 3 PUFA Market?
Ans- This can be attributable to increased research and development as well as enhanced medicine penetration.
5. What are the top players operating in Omega 3 PUFA Market?
Ans- Cargill Incorporated, FMC Corporation, Croda International PLC, Royal DSM, Omega Protein Corporation, and Arista Industries Inc.